MicroRNAs (miRNAs) are small noncoding RNAs stretching over 18–22 nucleotides and
considered to be modifiers of many respiratory diseases. They are highly evolutionary …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent
responsible for the Coronavirus Disease-2019 (COVID-19) pandemic, has infected over 185 …

Secretory phospholipase-IIA A2 (sPLA2-IIA) is expressed in a variety of cell types under
inflammatory conditions. Its presence in the bronchoalveolar lavage (BAL) fluid of patients …

Increased procoagulant activity in the alveolar compartment and uncontrolled inflammation
are hallmarks of the acute respiratory distress syndrome (ARDS). Here, we investigated …

Because this year is the golden anniversary of the first clinical description of ARDS in 1967,
we have used the acronym 'GOLDEN'to frame our review. It is clear that although much has …

Acute respiratory distress syndrome (ARDS) is a multifactorial syndrome with high morbidity
and mortality rates, characterized by deficiency in gas exchange and lung mechanics that …

Progranulin (PGRN), which plays an anti‐inflammatory role in acute lung injury (ALI), is
promising as a potential drug. Studies have shown that regulatory T cells (Tregs) and …

The remodeling of the extracellular matrix (ECM) in the parenchyma plays an important role
in the development of acute respiratory distress syndrome (ARDS), a disease characterized …

Acute lung injury (ALI) is a frequent and challenging aspect of sepsis that currently lacks
effective treatments. Procyanidin B2 (PB2) has anti-inflammatory and antioxidant properties …

Acute respiratory distress syndrome (ARDS) is a syndrome, a combination of clinical and
physiological observations that describe a pathological state. The pathogenesis of ARDS is …